| Financial Year |
March 31 2023 |
| Monetary Funds |
3,216,719,677.03 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
409,488,296.50 |
| Accounts Receivable |
806,114,644.88 |
| Advances to Suppliers |
345,318,447.49 |
| Other Receivables |
60,932,383.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,022,861,498.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
954,896,795.47 |
| Total Current Assets |
8,167,166,637.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
50,591,646.71 |
| Investment Properties |
-- |
| Fixed Assetes |
9,903,227,999.83 |
| Under-construction Projects |
3,500,143,617.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,942,100,883.74 |
| R&D expenses |
-- |
| Goodwill |
2,998,190.02 |
| Long-Term Deferred and Prepaid Expenses |
163,618,821.59 |
| Deferred Income Tax Assets |
368,654,969.05 |
| Other Non-Current Assets |
1,653,111,253.77 |
| Sub-Total of Non-Current Assets |
17,753,922,380.95 |
| Total Assets |
25,921,089,018.60 |
| Short-Term Loans |
908,720,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
555,621,033.98 |
| Accounts Payable |
2,040,905,559.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
436,378,185.16 |
| Taxes Payable |
115,699,239.62 |
| Interest Payable |
11,523,414.83 |
| Dividend Payable |
-- |
| Other payables |
1,071,780,798.15 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
357,898,542.86 |
| Other Current Liabilities |
223,452,952.39 |
| Sub-Total of Current Liabilities |
5,792,856,772.95 |
| Long-term Loans |
4,962,443,246.96 |
| Bonds Payable |
1,270,831,007.47 |
| Long-Term Accounts Payable |
3,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
19,580,162.55 |
| Deferred Income Tax Liabilities |
196,506,108.75 |
| Other Non-Current Liabilities |
105,391,780.81 |
| Sub-Total of Non-Current Liabilities |
7,039,628,595.74 |
| Total Liabilities |
12,832,485,368.69 |
| Paid-In Capital(Or Share Stock) |
2,683,500,504.00 |
| Capital Surplus |
2,530,439,112.28 |
| Surplus Reserve |
1,075,161,708.69 |
| LESS:Treasury Stock |
172,078,657.15 |
| Undistributed Profits |
6,344,878,993.01 |
| Minority Stockholder's Interest |
341,286,921.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,747,316,728.48 |
| Owner's Equity（Stockholder's Equity） |
13,088,603,649.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
25,921,089,018.60 |
